Tag: sources

  • Unique: Catalent is reviewing choices in accordance with Elliott Deal sources

    A basic view of the biologics and sterile injectable drug manufacturing laboratory, Catalent, in Brussels, Belgium June 27, 2023. Portal/Yves Herman LICENSES RIGHTS Aug 29 (Portal) – (This Aug 28 article was resubmitted to appropriate the spelling of Elliott within the headline.) Catalent Inc (CTLT.N) is near reaching an settlement with activist investor Elliott Funding…